Vyant Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vyant Bio's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 42% to $666,000. The net income raised on -$22,690,000 and profit margin reached -3407%. Total operating expenses were $15,570,000.

Profit Margin

Vyant Bio, Inc. (NASDAQ:VYNT): Profit margin
2013 6.60M -12.37M -187.18%
2014 10.19M -16.64M -163.18%
2015 18.04M -20.18M -111.88%
2016 27.04M -15.80M -58.42%
2017 29.12M -20.88M -71.7%
2018 27.47M -20.37M -74.16%
2019 7.30M -6.70M -91.83%
2020 867K -9.19M -1060.67%
2021 1.14M -46.09M -4015.24%
2022 666K -22.69M -3406.91%

VYNT Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
666K1.14M867K7.30M27.47M29.12M27.04M18.04M10.19M6.60M
Cost of revenue
1.00M1.84M1.10M3.70M18.72M18.07M17.10M14.09M8.45M4.92M
Gross profit
-342K-699K-234K3.60M8.74M11.05M9.94M3.94M1.74M1.68M
Operating exp.
Research and development
6.77M4.27M3.23M02.48M4.78M5.96M5.48M4.62M2.19M
Selling and marketing
8.79M8.42M2.71M1.14M5.26M4.99M4.66M5.26M3.96M1.84M
Total operating expenses
15.57M12.69M5.94M6.31M26.94M29.67M26.66M25.31M20.95M10.14M
Operating income
-15.91M-15.70M-7.62M-2.71M-18.19M-18.62M-16.72M-21.37M-19.20M-8.46M
Other income (expenses), net
105K-2.86M-1.02M-4.68M-2.17M-4.33M921K9K215.98K-4.57M
Income before tax
-15.80M-18.57M-8.65M-7.39M-20.37M-22.95M-15.80M-21.36M-18.99M-13.03M
Income tax expense
6.88M27.52M546K-512K-59K-2.07M1.37M-1.18M-2.35M-663.9K
Net income
-22.69M-46.09M-9.19M-6.70M-20.37M-20.88M-15.80M-20.18M-16.64M-12.37M
Earnings per share
Basic EPS
-3.87-10.19-18.5-17.4-111.98-151.58-149.45-294-264.2-397.81
Diluted EPS
-3.87-10.19-18.5-17.4-111.98-151.58-149.45-293.97-263.85-396.9
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source